SCHEMBL496176

SCHEMBL496176

CN(Cc1ccccc1)C[C@H](O)[C@H](N)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.51
DNM1 Q05193 1/20 0.47
CARM1 Q86X55 1/20 0.46
PRMT6 Q96LA8 1/20 0.46
PRMT8 Q9NR22 1/20 0.46
EPHX1 P07099 1/20 0.46
SLC6A2 P23975 3/20 0.45
SLC6A4 P31645 2/20 0.45
SLC6A3 Q01959 2/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
HTR2A P28223 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRK1 P41145 1/20 0.45
KCNH2 Q12809 1/20 0.45
SPPL2A Q8TCT8 1/20 0.44
TAAR1 Q96RJ0 2/20 0.43
MAOA P21397 1/20 0.43
HPGD P15428 1/20 0.43
SIGMAR1 Q99720 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL496241 0.98 CSNK1E (0.50) CSNK1EDNM1CARM1PRMT6PRMT8
SCHEMBL22626653 0.87 SPPL2A (0.53) CSNK1EEPHX1SLC6A2SLC6A4SLC6A3
SCHEMBL13118762 0.87 SPPL2A (0.53) CSNK1EEPHX1SLC6A2SLC6A4SLC6A3
SCHEMBL496237 0.85 CSNK1E (0.55) CSNK1EEPHX1SLC6A2SLC6A4SLC6A3
SCHEMBL496229 0.84 CSNK1E (0.49) CSNK1EEPHX1SPPL2ATAAR1SIGMAR1
SCHEMBL8125895 0.84 KMT2A (0.52) HTR2ATAAR1AOC3KDM4EMEN1
SCHEMBL8347358 0.84 KMT2A (0.52) HTR2ATAAR1AOC3KDM4EMEN1
SCHEMBL12595652 0.84 UGT1A1 (0.45) CSNK1EDNM1OPRK1KCNH2SPPL2A
Hydrochloric Acid SCHEMBL496260 0.83 CSNK1E (0.54) CSNK1EEPHX1SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL15062952 0.83 CSNK1E (0.54) CSNK1EEPHX1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910317-B1 1-AMINO LINKED COMPOUNDS LILLY CO ELI (US) 2013-07-03 EP disclosed
EP-1910317-B1 1-AMINO LINKED COMPOUNDS LILLY CO ELI (US) 2013-07-03 EP disclosed
US-8106090-B2 Antidiabetic agents; prevent of non-insulin dependent diabetes ELI LILLY AND COMPANY (US) 2012-01-31 US disclosed
US-8106090-B2 Antidiabetic agents; prevent of non-insulin dependent diabetes ELI LILLY AND COMPANY (US) 2012-01-31 US disclosed
US-8106090-B2 Antidiabetic agents; prevent of non-insulin dependent diabetes ELI LILLY AND COMPANY (US) 2012-01-31 US disclosed
US-20080207735-A1 1-Amino Linked Compounds ELI LILLY AND COMPANY 2008-08-28 US disclosed
US-20080207735-A1 1-Amino Linked Compounds ELI LILLY AND COMPANY 2008-08-28 US disclosed
US-20080207735-A1 1-Amino Linked Compounds ELI LILLY AND COMPANY 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207735-A1 1-Amino Linked Compounds DPP4, DPP3, DPP9 CSNK1E 194/4885DNM1 3851/4885CARM1 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.